These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22511552)

  • 1. Imbalanced mortality evidence for tigecycline: 2011, the year of the meta-analysis.
    Verde PE; Curcio D
    Clin Infect Dis; 2012 Aug; 55(3):471-2. PubMed ID: 22511552
    [No Abstract]   [Full Text] [Related]  

  • 2. Tigecycline: a single antibiotic for polymicrobial infections.
    Pankey GA; Steele RW
    Pediatr Infect Dis J; 2007 Jan; 26(1):77-8. PubMed ID: 17195711
    [No Abstract]   [Full Text] [Related]  

  • 3. More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates.
    Martín-Gandul C; García-Cabrera E; Castillo-Ojeda E; Jiménez-Mejías ME
    J Antimicrob Chemother; 2012 Apr; 67(4):1048-9. PubMed ID: 22207597
    [No Abstract]   [Full Text] [Related]  

  • 4. Tigecycline: benefits and risks.
    Cai Y; Wang R
    Lancet Infect Dis; 2011 Nov; 11(11):804-5. PubMed ID: 21784707
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of minocycline and tigecycline in a hamster model of leptospirosis.
    Tully CC; Hinkle MK; McCall S; Griffith ME; Murray CK; Hospenthal DR
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):366-9. PubMed ID: 22018938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label use of antibiotics in hospitalized patients: focus on tigecycline.
    Curcio D
    J Antimicrob Chemother; 2009 Dec; 64(6):1344-6. PubMed ID: 19759045
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness and safety of tigecycline: focus on use for approved indications.
    Vardakas KZ; Rafailidis PI; Falagas ME
    Clin Infect Dis; 2012 Jun; 54(11):1672-4. PubMed ID: 22431809
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections.
    Routsi C; Kokkoris S; Douka E; Ekonomidou F; Karaiskos I; Giamarellou H
    Int J Antimicrob Agents; 2015 Jan; 45(1):90-3. PubMed ID: 25241261
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrospinal fluid penetration of tigecycline.
    Pallotto C; Fiorio M; D'Avolio A; Sgrelli A; Baldelli F; Di Perri G; De Socio GV
    Scand J Infect Dis; 2014 Jan; 46(1):69-72. PubMed ID: 24131423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacterial resistance and a new antibiotic: tigecycline].
    Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):209-19. PubMed ID: 17099789
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with the first glycylcycline--tigecycline].
    Musch A
    Med Monatsschr Pharm; 2006 May; 29(5):191-2. PubMed ID: 16719269
    [No Abstract]   [Full Text] [Related]  

  • 12. Off-label prescription of tigecycline: clinical and microbiological characteristics and outcomes.
    Conde-Estévez D; Grau S; Horcajada JP; Luque S
    Int J Antimicrob Agents; 2010 Nov; 36(5):471-2. PubMed ID: 20828992
    [No Abstract]   [Full Text] [Related]  

  • 13. What role for tigecycline in infections?
    BMJ Group
    Drug Ther Bull; 2008 Aug; 46(8):62-4. PubMed ID: 18687585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing the role of tigecycline in an era of antimicrobial resistance.
    Schafer JJ; Goff DA
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization.
    Falagas ME; Metaxas EI
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):913-23. PubMed ID: 19803699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New intravenous antibiotics: a focused pharmacotherapy update.
    Connor KA
    AACN Adv Crit Care; 2010; 21(3):237-40; quiz 242. PubMed ID: 20683221
    [No Abstract]   [Full Text] [Related]  

  • 17. Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint.
    Burkhardt O; Rauch K; Kaever V; Hadem J; Kielstein JT; Welte T
    Int J Antimicrob Agents; 2009 Jul; 34(1):101-2. PubMed ID: 19278835
    [No Abstract]   [Full Text] [Related]  

  • 18. Tigecycline: a new glycylcycline for treatment of serious infections.
    Noskin GA
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S303-14. PubMed ID: 16080069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute necrotizing pancreatitis related to tigecycline.
    Mascarello M; Papa G; Arnez ZM; Luzzati R
    J Antimicrob Chemother; 2012 May; 67(5):1296-7. PubMed ID: 22279181
    [No Abstract]   [Full Text] [Related]  

  • 20. Tigecycline.
    Prescrire Int; 2007 Dec; 16(92):245. PubMed ID: 18092414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.